Decision Makers
Vice President Of Strategic Partnerships
Ed Steres is in control of choosing strategically significant development path for Bdi Pharma, Inc. E-mail: e****@gmail.com, Phone: 18037321018 is available on SoftwareOfficial.
Senior Vp, Sales And Strategic Accounts
They are the top-level leaders and usually review internal operations, develop future vision of the company and evaluate managers performance E-mail: d****@gmail.com, Phone: 18037321018 is available on SoftwareOfficial.
Owner
Edward Stiefel is in charge of choosing strategically significant development path. E-mail: e****@hotmail.com, Phone: 18037321018 is available on SoftwareOfficial.
Company Details
Last Update
Jul 13, 2022
Location
120 Research Dr, Columbia, SC 29203
5400 Big Tyler Rd, Charleston, WV 25313
Phone
(***) ***-1018
Industry
Pharmaceuticals
Whol Drugs/Sundries
Category
Drug Stores & Pharmacies
Health & Beauty Aids Retail
Specialties
Distribution, Sales, Marketing
Specialty Pharmaceuticals
Plasma Derivatives / Recombinant Therapeutics
FLU Vaccines
Founded
1995
Number of Employee
51-200 employees
NAICS
722 - Food Services and Drinking Places
Site
FAQs about decision-makers at BDI Pharma, Inc
What is the probable address of the Bdi Pharma, Inc?
The company Bdi Pharma address is in Columbia, South Carolina state.
What are the industries connected with Bdi Pharma?
The industries connected with the company Bdi Pharma are Pharmaceuticals and Whol Drugs/Sundries.
Is there any way to connect with Bdi Pharma?
The phone of the company Bdi Pharma decision-makers is 18037321018.
What are the names of the main decision-makers in Bdi Pharma?
The decision-makers of the company are Debra Aronson, Ed Steres etc.
What are the specialties of the main decision-makers in Bdi Pharma?
The professions of the company decision-makers are Vice President of Strategic Partnerships or Senior Vp, Sales and Strategic Accounts etc.
What are the fields for Bdi Pharma?
The specialties for Bdi Pharma are Distribution, Sales, Marketing, Specialty Pharmaceuticals, Plasma Derivatives / Recombinant Therapeutics, and FLU Vaccines